Beam Therapeutics Stock (NASDAQ: BEAM) stock price, news, charts, stock research, profile.
You can purchase shares of Beam Therapeutics (NASDAQ:BEAM) through any online brokerage.
Other companies in Beam Therapeutics’s space includes: Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), CareDx (NASDAQ:CDNA), Arrowhead Pharma (NASDAQ:ARWR) and Agios Pharmaceuticals (NASDAQ:AGIO).
Beam Therapeutics has a consensus price target of $60.65.
The stock price for Beam Therapeutics (NASDAQ: BEAM) is $23.35 last updated October 4, 2024 at 5:38 PM EDT.
A quarterly cash dividend of 0.23 per share of Class A Common Stock. The quarterly cash dividend was payable on March 3, 2014 to stockholders of record on February 4, 2014.
Beam Therapeutics’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for Beam Therapeutics.
Beam Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.